PET staging of amyloidosis using striatum
Bernard Hanseeuw(Cliniques Universitaires Saint-Luc), Reisa A. Sperling(Harvard University), Aaron P. Schultz(Harvard University), Jorge Sepulcre(Harvard University), J. Alex Becker(Jacobson Holman (United States)), Rebecca A. Betensky(Harvard University), Rachel F. Buckley(Harvard University), Gad A. Marshall, Patrizia Vannini(Harvard University), Nancy J. Donovan(Brigham and Women's Hospital), Kathryn V. Papp(Brigham and Women's Hospital), Dorene M. Rentz(Brigham and Women's Hospital), Elizabeth C. Mormino(Allen Institute for Brain Science), Rebecca E. Amariglio(Harvard University), Molly R. LaPoint, Jasmeer P. Chhatwal(Harvard University), Heidi I.L. Jacobs(Harvard University), Keith A. Johnson(Brigham and Women's Hospital)
Cited by 136
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k